Pacira BioSciences PCRX Stock
Pacira BioSciences Price Chart
Pacira BioSciences PCRX Financial and Trading Overview
| Pacira BioSciences stock price | 25.2 USD |
| Previous Close | 38.74 USD |
| Open | 38.74 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 38.54 - 40.32 USD |
| 52 Week Range | 35.35 - 59.33 USD |
| Volume | 571.89K USD |
| Avg. Volume | 540.86K USD |
| Market Cap | 2.01B USD |
| Beta (5Y Monthly) | 0.761083 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.3 USD |
PCRX Valuation Measures
| Enterprise Value | 2.11B USD |
| Trailing P/E | N/A |
| Forward P/E | 9.122171 |
| PEG Ratio (5 yr expected) | 0.42 |
| Price/Sales (ttm) | 2.997249 |
| Price/Book (mrq) | 2.4133596 |
| Enterprise Value/Revenue | 3.157 |
| Enterprise Value/EBITDA | 14.153 |
Trading Information
Pacira BioSciences Stock Price History
| Beta (5Y Monthly) | 0.761083 |
| 52-Week Change | -24.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 59.33 USD |
| 52 Week Low | 35.35 USD |
| 50-Day Moving Average | 41.6 USD |
| 200-Day Moving Average | 44.67 USD |
PCRX Share Statistics
| Avg. Volume (3 month) | 540.86K USD |
| Avg. Daily Volume (10-Days) | 639.02K USD |
| Shares Outstanding | 45.99M |
| Float | 45.44M |
| Short Ratio | 6.45 |
| % Held by Insiders | 1.10% |
| % Held by Institutions | 109.07% |
| Shares Short | 3.52M |
| Short % of Float | 10.72% |
| Short % of Shares Outstanding | 7.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.56% |
| Operating Margin (ttm) | 10.26% |
| Gross Margin | 57.84% |
| EBITDA Margin | 22.30% |
Management Effectiveness
| Return on Assets (ttm) | 2.51% |
| Return on Equity (ttm) | -1.41% |
Income Statement
| Revenue (ttm) | 669.17M USD |
| Revenue Per Share (ttm) | 14.61 USD |
| Quarterly Revenue Growth (yoy) | 1.50% |
| Gross Profit (ttm) | 393.23M USD |
| EBITDA | 149.28M USD |
| Net Income Avi to Common (ttm) | -10455000 USD |
| Diluted EPS (ttm) | -0.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 174M USD |
| Total Cash Per Share (mrq) | 3.78 USD |
| Total Debt (mrq) | 625.16M USD |
| Total Debt/Equity (mrq) | 81.4 USD |
| Current Ratio (mrq) | 3.811 |
| Book Value Per Share (mrq) | 16.707 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 133.63M USD |
| Levered Free Cash Flow (ttm) | 114.02M USD |
Profile of Pacira BioSciences
| Country | United States |
| State | FL |
| City | Tampa |
| Address | 5401 West Kennedy Boulevard |
| ZIP | 33609 |
| Phone | 813 553 6680 |
| Website | https://www.pacira.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 715 |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Q&A For Pacira BioSciences Stock
What is a current PCRX stock price?
Pacira BioSciences PCRX stock price today per share is 25.2 USD.
How to purchase Pacira BioSciences stock?
You can buy PCRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacira BioSciences?
The stock symbol or ticker of Pacira BioSciences is PCRX.
Which industry does the Pacira BioSciences company belong to?
The Pacira BioSciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Pacira BioSciences have in circulation?
The max supply of Pacira BioSciences shares is 46.75M.
What is Pacira BioSciences Price to Earnings Ratio (PE Ratio)?
Pacira BioSciences PE Ratio is now.
What was Pacira BioSciences earnings per share over the trailing 12 months (TTM)?
Pacira BioSciences EPS is -2.13 USD over the trailing 12 months.
Which sector does the Pacira BioSciences company belong to?
The Pacira BioSciences sector is Healthcare.
Pacira BioSciences PCRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16708.05 USD — |
+2.5
|
7.57B USD — | 16642.66 USD — | 17029.86 USD — | — - | 7.57B USD — |
| NASDAQ Biotechnology NBI | 4116.15 USD — |
+1.68
|
— — | 4101.26 USD — | 4187.02 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 911.61 USD — |
+1.7
|
— — | 909.68 USD — | 929.8 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4453.6 USD — |
+1.68
|
— — | 4437.49 USD — | 4530.28 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value N NQUS700SCVN | 2076.4 USD — |
+0.99
|
— — | 2069.73 USD — | 2139.19 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2024.37 USD — |
+1.4
|
— — | 2019.11 USD — | 2078.05 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8168.22 USD — |
+2.5
|
— — | 8135.98 USD — | 8324.83 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4124.19 USD — |
+3.5
|
— — | 3927.42 USD — | 4124.19 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 20452.28 USD — |
+2.5
|
— — | 20372.24 USD — | 20846.21 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value I NQUS700SCV | 1844.74 USD — |
+0.98
|
— — | 1838.81 USD — | 1900.52 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1307.81 USD — |
+0.42
|
— — | 1301.65 USD — | 1326.48 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2692.5 USD — |
+1.79
|
— — | 2683.46 USD — | 2752.7 USD — | — - | — — |
- {{ link.label }} {{link}}